{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:10:21Z","timestamp":1790759421363,"version":"4.1.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["EHD15PI05\/2016"],"award-info":[{"award-number":["EHD15PI05\/2016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00598"],"award-info":[{"award-number":["PI16\/00598"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00819"],"award-info":[{"award-number":["PI19\/00819"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Junta de Castilla y Le\u00f3n Consejer\u00eda de Educaci\u00f3n","doi-asserted-by":"publisher","award":["SA063P17"],"award-info":[{"award-number":["SA063P17"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Junta de Andalucia Consejeria de Economia Innovacion Ciencia y Empleo","doi-asserted-by":"publisher","award":["CTS164"],"award-info":[{"award-number":["CTS164"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Junta de Andalucia Consejeria de Economia Innovacion Ciencia y Empleo","doi-asserted-by":"publisher","award":["CTS235"],"award-info":[{"award-number":["CTS235"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundacio la Marato de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","award":["SAF2017-88457-R"],"award-info":[{"award-number":["SAF2017-88457-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","award":["AGL2017-85270-R"],"award-info":[{"award-number":["AGL2017-85270-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","award":["SAF2016-75197-R"],"award-info":[{"award-number":["SAF2016-75197-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014064","name":"University of Salamanca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["2017\/2020"],"award-info":[{"award-number":["2017\/2020"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bcp.2021.114810","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T20:17:14Z","timestamp":1634674634000},"page":"114810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Impact of alternative splicing on mechanisms of resistance to anticancer drugs"],"prefix":"10.1016","volume":"193","author":[{"given":"Maria","family":"Reviejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meraris","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-6053","authenticated-orcid":false,"given":"Maitane","family":"Asensio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mart\u00ednez-Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn","family":"S\u00e1nchez de Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J.G.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tig.2015.01.001","article-title":"Alternative mRNA transcription, processing, and translation: insights from RNA sequencing","volume":"31","author":"de Klerk","year":"2015","journal-title":"Trends Genet."},{"issue":"Pt B","key":"10.1016\/j.bcp.2021.114810_b0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biocel.2017.05.023","article-title":"A matter of maturity: The impact of pre-mRNA processing in gene expression and antigen presentation","volume":"91","author":"Martins","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7280","key":"10.1016\/j.bcp.2021.114810_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature08909","article-title":"Expansion of the eukaryotic proteome by alternative splicing","volume":"463","author":"Nilsen","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.115.307872","article-title":"Regulation and Dysregulation in the Heart","volume":"118","author":"van den Hoogenhof","year":"2016","journal-title":"Circ. Res."},{"issue":"7221","key":"10.1016\/j.bcp.2021.114810_b0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07509","article-title":"Alternative isoform regulation in human tissue transcriptomes","volume":"456","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114810_b0030","first-page":"77","article-title":"Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers","volume":"9","author":"Mthembu","year":"2017","journal-title":"HIV AIDS (Auckl)"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071085","article-title":"Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy","volume":"12","author":"Mehterov","year":"2021","journal-title":"Genes (Basel)"},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061663","article-title":"Molecular Bases of Drug Resistance in Hepatocellular Carcinoma","volume":"12","author":"Marin","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/13543784.2021.1916912","article-title":"Understanding drug resistance mechanisms in cholangiocarcinoma: assisting the clinical development of investigational drugs","volume":"30","author":"Marin","year":"2021","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-1119(89)90034-6","article-title":"Group I introns as mobile genetic elements: facts and mechanistic speculations\u2013a review","volume":"82","author":"Dujon","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2021.114810_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.bi.62.070193.003103","article-title":"Introns as mobile genetic elements","volume":"62","author":"Lambowitz","year":"1993","journal-title":"Annu. Rev. Biochem."},{"issue":"51","key":"10.1016\/j.bcp.2021.114810_b0060","doi-asserted-by":"crossref","first-page":"30237","DOI":"10.1074\/jbc.270.51.30237","article-title":"Mechanisms of intron mobility","volume":"270","author":"Belfort","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2021.114810_b0065","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1093\/nar\/18.17.5133","article-title":"Nuclear pre-mRNA introns: analysis and comparison of intron sequences from Tetrahymena thermophila and other eukaryotes","volume":"18","author":"Csank","year":"1990","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114810_b0070","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1093\/nar\/gkz270","article-title":"Impact of intron removal from tRNA genes on Saccharomyces cerevisiae","volume":"47","author":"Hayashi","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"5256","key":"10.1016\/j.bcp.2021.114810_b0075","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1126\/science.271.5256.1716","article-title":"Requirement of U12 snRNA for in vivo splicing of a minor class of eukaryotic nuclear pre-mRNA introns","volume":"271","author":"Hall","year":"1996","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0092-8674(00)80479-1","article-title":"Classification of introns: U2-type or U12-type","volume":"91","author":"Sharp","year":"1997","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2021.114810_b0085","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nrm1259","article-title":"Splicing double: insights from the second spliceosome","volume":"4","author":"Patel","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114810_b0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2777","article-title":"Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches","volume":"10","author":"Chen","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0968-0004(97)01018-9","article-title":"Pre-mRNA splicing: the discovery of a new spliceosome doubles the challenge","volume":"22","author":"Tarn","year":"1997","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0955-0674(99)80050-7","article-title":"Determinants of SR protein specificity","volume":"11","author":"Tacke","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"issue":"19\u201320","key":"10.1016\/j.bcp.2021.114810_b0105","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-004-4190-0","article-title":"The special Sm core structure of the U7 snRNP: far-reaching significance of a small nuclear ribonucleoprotein","volume":"61","author":"Schumperli","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/nar\/gks1097","article-title":"Structure, phosphorylation and U2AF65 binding of the N-terminal domain of splicing factor 1 during 3'-splice site recognition","volume":"41","author":"Zhang","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.emboj.7600050","article-title":"Prp5 bridges U1 and U2 snRNPs and enables stable U2 snRNP association with intron RNA","volume":"23","author":"Xu","year":"2004","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/biom5020893","article-title":"RNA-Binding Proteins: Splicing Factors and Disease","volume":"5","author":"Fredericks","year":"2015","journal-title":"Biomolecules"},{"issue":"6438","key":"10.1016\/j.bcp.2021.114810_b0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.aax3289","article-title":"Mechanism of 5' splice site transfer for human spliceosome activation","volume":"364","author":"Charenton","year":"2019","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0130","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/emboj\/21.5.1148","article-title":"Protein 61K, encoded by a gene (PRPF31) linked to autosomal dominant retinitis pigmentosa, is required for U4\/U6*U5 tri-snRNP formation and pre-mRNA splicing","volume":"21","author":"Makarova","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2021.114810_b0135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23533","article-title":"Identification of a small molecule inhibitor that stalls splicing at an early step of spliceosome activation","volume":"6","author":"Sidarovich","year":"2017","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.bcp.2021.114810_b0140","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/jcb.24625","article-title":"The U5 snRNA internal loop 1 is a platform for Brr2, Snu114 and Prp8 protein binding during U5 snRNP assembly","volume":"114","author":"Nancollis","year":"2013","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1261\/rna.042598.113","article-title":"The DExD\/H-box ATPase Prp2p destabilizes and proofreads the catalytic RNA core of the spliceosome","volume":"20","author":"Wlodaver","year":"2014","journal-title":"RNA"},{"issue":"7475","key":"10.1016\/j.bcp.2021.114810_b0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature12734","article-title":"RNA catalyses nuclear pre-mRNA splicing","volume":"503","author":"Fica","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0968-0004(90)90075-M","article-title":"Self-splicing group II and nuclear pre-mRNA introns: how similar are they?","volume":"15","author":"Jacquier","year":"1990","journal-title":"Trends Biochem. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003707","article-title":"Spliceosome structure and function","volume":"3","author":"Will","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0165","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1017\/S1355838200000960","article-title":"Sorting out the complexity of SR protein functions","volume":"6","author":"Graveley","year":"2000","journal-title":"RNA"},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20081501","article-title":"The SR protein family of splicing factors: master regulators of gene expression","volume":"417","author":"Long","year":"2009","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0968-0004(00)01549-8","article-title":"Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases","volume":"25","author":"Blencowe","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2021.114810_b0180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.cb.09.110193.001405","article-title":"Macromolecular domains within the cell nucleus","volume":"9","author":"Spector","year":"1993","journal-title":"Annu. Rev. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/gb-2009-10-10-242","article-title":"The SR protein family","volume":"10","author":"Shepard","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.bcp.2021.114810_b0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-0-387-77374-2_8","article-title":"hnRNP proteins and splicing control","volume":"623","author":"Martinez-Contreras","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2021.114810_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/151839","article-title":"Phosphorylation-mediated regulation of alternative splicing in cancer","volume":"2013","author":"Naro","year":"2013","journal-title":"Int J Cell Biol"},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tig.2012.01.001","article-title":"New connections between splicing and human disease","volume":"28","author":"Padgett","year":"2012","journal-title":"Trends Genet."},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004732","article-title":"A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis","volume":"4","author":"He","year":"2009","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0210","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/nar\/gkz1213","article-title":"ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin","volume":"48","author":"Tanaka","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0215","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/nar\/gku1392","article-title":"Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer","volume":"43","author":"Sebestyen","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0220","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1093\/nar\/gkv210","article-title":"Identification of recurrent regulated alternative splicing events across human solid tumors","volume":"43","author":"Danan-Gotthold","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0225","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/0008-5472.CAN-16-1919","article-title":"SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development","volume":"77","author":"Luo","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.molcel.2020.10.019","article-title":"Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis","volume":"80","author":"Leclair","year":"2020","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tig.2007.10.001","article-title":"Insights into the connection between cancer and alternative splicing","volume":"24","author":"Kim","year":"2008","journal-title":"Trends Genet."},{"issue":"Pt 13","key":"10.1016\/j.bcp.2021.114810_b0240","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1242\/jcs.03053","article-title":"The connection between splicing and cancer","volume":"119","author":"Srebrow","year":"2006","journal-title":"J. Cell Sci."},{"issue":"25","key":"10.1016\/j.bcp.2021.114810_b0245","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.3748\/wjg.v16.i25.3091","article-title":"Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences","volume":"16","author":"Berasain","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.bcp.2021.114810_b0250","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.biocel.2007.04.004","article-title":"Signals, pathways and splicing regulation","volume":"39","author":"Blaustein","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","article-title":"Noncoding RNAs regulate alternative splicing in Cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13059-020-02240-8","article-title":"Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer","volume":"22","author":"Oka","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.bcp.2021.114810_b0265","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2020.10.010","article-title":"Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma","volume":"496","author":"Lopez-Canovas","year":"2021","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165687","article-title":"Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma","volume":"1866","author":"Soto","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010010","article-title":"Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors","volume":"9","author":"Bielli","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13059-016-0990-4","article-title":"Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma","volume":"17","author":"Correa","year":"2016","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0285","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41419-019-1929-y","article-title":"SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0290","doi-asserted-by":"crossref","first-page":"15488","DOI":"10.1038\/s41598-017-15448-9","article-title":"Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis","volume":"7","author":"Ji","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2021.114810_b0295","first-page":"3567","article-title":"Poly r(C) binding protein (PCBP) 1 is a negative regulator of thyroid carcinoma","volume":"8","author":"Zhang","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.bcp.2021.114810_b0300","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopha.2017.07.103","article-title":"High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma","volume":"94","author":"Luo","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0305","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/2211-5463.12408","article-title":"Poly(rC) binding protein 2 (PCBP2) promotes the viability of human gastric cancer cells by regulating CDK2","volume":"8","author":"Chen","year":"2018","journal-title":"FEBS Open Bio"},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nsmb1209","article-title":"The gene encoding the splicing factor SF2\/ASF is a proto-oncogene","volume":"14","author":"Karni","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000338941","article-title":"Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia","volume":"35","author":"Liu","year":"2012","journal-title":"Onkologie"},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0320","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bbamcr.2018.05.017","article-title":"SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma","volume":"1865","author":"Yang","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Res."},{"issue":"18","key":"10.1016\/j.bcp.2021.114810_b0325","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41388-017-0119-6","article-title":"SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-kappaB-CD47 axis","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0330","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI120279","article-title":"Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B","volume":"129","author":"Zhou","year":"2019","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2021.114810_b0335","first-page":"137","article-title":"Regulation of SRp20 exon 4 splicing","volume":"1494","author":"Jumaa","year":"2000","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0340","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/febs.15531","article-title":"A guide to plasma membrane solute carrier proteins","volume":"288","author":"Pizzagalli","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2021.114810_b0345","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/692071","article-title":"Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology","volume":"2013","author":"Lozano","year":"2013","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0350","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.26425","article-title":"Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib","volume":"58","author":"Herraez","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0355","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bjh.12591","article-title":"A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia","volume":"163","author":"Grinfeld","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2021.114810_b0360","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12885-016-2150-3","article-title":"Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment","volume":"16","author":"Grimm","year":"2016","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0365","doi-asserted-by":"crossref","first-page":"15846","DOI":"10.18632\/oncotarget.15029","article-title":"The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma","volume":"8","author":"Geier","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0370","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-07-5528","article-title":"Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells","volume":"68","author":"Cai","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2021.114810_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CEG.S3743","article-title":"Organic anion transporting polypeptide 1B3 (OATP1B3) is overexpressed in colorectal tumors and is a predictor of clinical outcome","volume":"1","author":"Lockhart","year":"2008","journal-title":"Clin Exp Gastroenterol"},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0380","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1349-7006.2007.00570.x","article-title":"Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma","volume":"98","author":"Muto","year":"2007","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1872312812666180326110146","article-title":"Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues","volume":"12","author":"Alam","year":"2018","journal-title":"Drug Metab. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0390","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbrc.2012.01.115","article-title":"Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells","volume":"418","author":"Nagai","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0395","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/mp3005353","article-title":"A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells","volume":"10","author":"Thakkar","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2021.114810_b0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40169-014-0037-y","article-title":"Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers","volume":"3","author":"Sun","year":"2014","journal-title":"Clin Transl Med"},{"issue":"14","key":"10.1016\/j.bcp.2021.114810_b0405","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-03-0439","article-title":"Alternative splicing of the multidrug resistance protein 1\/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20","volume":"10","author":"He","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0410","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/jpet.107.127027","article-title":"Expression and characterization of a human carboxylesterase 2 splice variant","volume":"323","author":"Schiel","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0415","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V96.4.1517","article-title":"High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia","volume":"96","author":"Veuger","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0420","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V99.4.1373","article-title":"Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells","volume":"99","author":"Veuger","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0425","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1074\/jbc.M110.163444","article-title":"Heterogeneous nuclear ribonucleoprotein H1\/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance","volume":"286","author":"Stark","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175998","article-title":"New advances in DPYD genotype and risk of severe toxicity under capecitabine","volume":"12","author":"Etienne-Grimaldi","year":"2017","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1016\/j.bcp.2021.114810_b0435","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1182\/blood-2008-08-173799","article-title":"Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia","volume":"113","author":"Stark","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0440","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.3324\/haematol.2016.142794","article-title":"The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia","volume":"101","author":"Wojtuszkiewicz","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0445","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ijc.29919","article-title":"Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance","volume":"138","author":"Wojtuszkiewicz","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"6892","key":"10.1016\/j.bcp.2021.114810_b0450","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0455","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"7377","key":"10.1016\/j.bcp.2021.114810_b0460","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature10662","article-title":"RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)","volume":"480","author":"Poulikakos","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114810_b0465","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1038\/ncomms8103","article-title":"Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing","volume":"6","author":"Salton","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0470","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.18632\/oncotarget.1802","article-title":"Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy","volume":"5","author":"Cao","year":"2014","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bcp.2021.114810_b0475","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1158\/1535-7163.MCT-17-0030","article-title":"Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells","volume":"16","author":"Tummala","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"21","key":"10.1016\/j.bcp.2021.114810_b0480","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1200\/JCO.2008.17.2254","article-title":"Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer","volume":"27","author":"Shi","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0485","first-page":"161","article-title":"Effects of DNA topoisomerase IIalpha splice variants on acquired drug resistance","volume":"3","author":"Elton","year":"2020","journal-title":"Cancer Drug Resist"},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0490","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.18632\/oncotarget.3898","article-title":"Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)","volume":"7","author":"Mohamed","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0495","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1158\/0008-5472.CAN-16-0186","article-title":"The BRCA1-Delta11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0500","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.264","article-title":"Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption","volume":"8","author":"Meyer","year":"2017","journal-title":"Cell Death Dis."},{"issue":"49","key":"10.1016\/j.bcp.2021.114810_b0505","doi-asserted-by":"crossref","first-page":"85759","DOI":"10.18632\/oncotarget.20482","article-title":"Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0510","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2010.07.019","article-title":"An alternative splicing network links cell-cycle control to apoptosis","volume":"142","author":"Moore","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0515","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/cb300602j","article-title":"Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells","volume":"8","author":"Gao","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0520","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/bjh.16472","article-title":"Correction of Bcl-x splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models","volume":"189","author":"Zhang","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0525","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nsmb.2207","article-title":"The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation","volume":"19","author":"Anczukow","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0530","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer","volume":"18","author":"Ng","year":"2012","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0535","doi-asserted-by":"crossref","first-page":"475","DOI":"10.21873\/cgp.20010","article-title":"Association of BIM Deletion Polymorphism and BIM-gamma RNA Expression in NSCLC with EGFR Mutation","volume":"13","author":"Isobe","year":"2016","journal-title":"Cancer Genomics Proteomics"},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0540","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000927","article-title":"The isoforms of the p53 protein","volume":"2","author":"Khoury","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0545","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3892\/ijo.2015.3188","article-title":"Targeting the 133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells","volume":"47","author":"Nutthasirikul","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114810_b0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172125","article-title":"The p53 isoform delta133p53ss regulates cancer cell apoptosis in a RhoB-dependent manner","volume":"12","author":"Arsic","year":"2017","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0555","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1158\/1078-0432.CCR-07-1422","article-title":"Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin","volume":"14","author":"Avery-Kiejda","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2021.114810_b0560","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/onc.2011.348","article-title":"Correlation analysis of p53 protein isoforms with NPM1\/FLT3 mutations and therapy response in acute myeloid leukemia","volume":"31","author":"Anensen","year":"2012","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bcp.2021.114810_b0565","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4161\/cc.6.12.4305","article-title":"The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein","volume":"6","author":"Knauer","year":"2007","journal-title":"Cell Cycle"},{"issue":"17","key":"10.1016\/j.bcp.2021.114810_b0570","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1158\/0008-5472.CAN-13-0036","article-title":"Survivin-3B potentiates immune escape in cancer but also inhibits the toxicity of cancer chemotherapy","volume":"73","author":"Vegran","year":"2013","journal-title":"Cancer Res."},{"issue":"11\u201312","key":"10.1016\/j.bcp.2021.114810_b0575","first-page":"541","article-title":"Survivin-3B gene decreases the invasion-inhibitory effect of colon cancer cells with 5-fluorouracil","volume":"18","author":"Sawai","year":"2010","journal-title":"Oncol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0580","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pbc.24822","article-title":"BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group","volume":"61","author":"Moore","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"Pt 4","key":"10.1016\/j.bcp.2021.114810_b0585","first-page":"788","article-title":"Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation","volume":"127","author":"Cope","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2021.114810_b0590","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1038\/ncomms15921","article-title":"Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.bcp.2021.114810_b0595","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/onc.2012.306","article-title":"Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2\/eIF4E pathway","volume":"32","author":"Adesso","year":"2013","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0600","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1158\/0008-5472.CAN-06-2969","article-title":"Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas","volume":"67","author":"Hayes","year":"2007","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.bcp.2021.114810_b0605","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/onc.2015.270","article-title":"Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells","volume":"35","author":"Calabretta","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0610","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/hep.30158","article-title":"Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer","volume":"69","author":"Li","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0615","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/0008-5472.CAN-20-1780","article-title":"Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL\/AKT Axis in Salivary Adenoid Cystic Carcinoma","volume":"81","author":"Humtsoe","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2021.114810_b0620","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jprot.2014.01.001","article-title":"Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling","volume":"99","author":"de Wit","year":"2014","journal-title":"J. Proteomics"},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0625","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccell.2018.05.012","article-title":"Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors","volume":"34","author":"Pavlyukov","year":"2018","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0630","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1074\/mcp.M115.052944","article-title":"Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis","volume":"15","author":"Wojtuszkiewicz","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.bcp.2021.114810_b0635","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/nar\/gkr819","article-title":"The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator","volume":"40","author":"Pedrotti","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114810_b0640","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-019-2045-8","article-title":"Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells","volume":"10","author":"Kolba","year":"2019","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0645","first-page":"e370","article-title":"Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab","volume":"18","author":"Pentheroudakis","year":"2019","journal-title":"Clin Colorectal Cancer"},{"issue":"25","key":"10.1016\/j.bcp.2021.114810_b0650","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1074\/jbc.RA119.008152","article-title":"Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"294","author":"Bai","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2021.114810_b0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002218","article-title":"An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype","volume":"7","author":"Shapiro","year":"2011","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0660","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-016-0579-2","article-title":"EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression","volume":"16","author":"Pradella","year":"2017","journal-title":"Mol Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2021.114810_b0665","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1101\/gad.241968.114","article-title":"Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing","volume":"28","author":"Xu","year":"2014","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0670","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1261\/rna.066712.118","article-title":"Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT","volume":"24","author":"Harvey","year":"2018","journal-title":"RNA"},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0675","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4161\/rna.6.5.9606","article-title":"The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events","volume":"6","author":"Warzecha","year":"2009","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0680","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1038\/s41598-017-05247-7","article-title":"CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156595","article-title":"CD44 Splice Variant v8\u201310 as a Marker of Serous Ovarian Cancer Prognosis","volume":"11","author":"Sosulski","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0690","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12885-018-3988-3","article-title":"Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer","volume":"18","author":"Hagiwara","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04138","article-title":"CD44v8-10 mRNA contained in serum exosomes as a diagnostic marker for docetaxel resistance in prostate cancer patients","volume":"6","author":"Kato","year":"2020","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0700","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1158\/0008-5472.CAN-13-2509","article-title":"HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL","volume":"74","author":"Zhou","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0705","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.molcel.2005.10.026","article-title":"Cell motility is controlled by SF2\/ASF through alternative splicing of the Ron protooncogene","volume":"20","author":"Ghigna","year":"2005","journal-title":"Mol. Cell"},{"issue":"142","key":"10.1016\/j.bcp.2021.114810_b0710","doi-asserted-by":"crossref","first-page":"142ra95","DOI":"10.1126\/scitranslmed.3004062","article-title":"Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression","volume":"4","author":"Stallings-Mann","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.bcp.2021.114810_b0715","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1074\/mcp.M112.027086","article-title":"Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition","volume":"12","author":"Tauro","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.bcp.2021.114810_b0720","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.3892\/or.2015.4286","article-title":"OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to omicronxaliplatin in colon cancer","volume":"34","author":"Wen","year":"2015","journal-title":"Oncol. Rep."},{"issue":"46","key":"10.1016\/j.bcp.2021.114810_b0725","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.18632\/oncotarget.27789","article-title":"HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes","volume":"11","author":"Hart","year":"2020","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0730","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105110","article-title":"Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities","volume":"22","author":"Blijlevens","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114810_b0735","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molmed.2015.11.005","article-title":"Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy","volume":"22","author":"Salton","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114810_b0740","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccell.2015.04.008","article-title":"Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo","volume":"27","author":"Shirai","year":"2015","journal-title":"Cancer Cell"},{"issue":"36","key":"10.1016\/j.bcp.2021.114810_b0745","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1021\/acs.biochem.7b00551","article-title":"Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs","volume":"56","author":"Glasser","year":"2017","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.bcp.2021.114810_b0750","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","volume":"118","author":"Malcovati","year":"2011","journal-title":"Blood"},{"issue":"7778","key":"10.1016\/j.bcp.2021.114810_b0755","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","article-title":"Spliceosomal disruption of the non-canonical BAF complex in cancer","volume":"574","author":"Inoue","year":"2019","journal-title":"Nature"},{"issue":"7424","key":"10.1016\/j.bcp.2021.114810_b0760","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0765","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/path.4483","article-title":"SF3B1 mutations constitute a novel therapeutic target in breast cancer","volume":"235","author":"Maguire","year":"2015","journal-title":"J. Pathol."},{"issue":"26","key":"10.1016\/j.bcp.2021.114810_b0770","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bcp.2021.114810_b0775","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1158\/1078-0432.CCR-16-2020","article-title":"Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer","volume":"23","author":"Chen","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114810_b0780","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/bloodadvances.2018015875","article-title":"Targeted next-generation sequencing in blast phase myeloproliferative neoplasms","volume":"2","author":"Lasho","year":"2018","journal-title":"Blood Adv."},{"issue":"9","key":"10.1016\/j.bcp.2021.114810_b0785","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","article-title":"Acute myeloid leukemia ontogeny is defined by distinct somatic mutations","volume":"125","author":"Lindsley","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2021.114810_b0790","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12967-015-0637-3","article-title":"Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer","volume":"13","author":"Kumar","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.bcp.2021.114810_b0795","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12935-019-1020-x","article-title":"hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing","volume":"19","author":"Peng","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"10","key":"10.1016\/j.bcp.2021.114810_b0800","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1245\/s10434-010-1121-1","article-title":"Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma","volume":"17","author":"Wen","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114810_b0805","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.bjc.6603349","article-title":"Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer","volume":"95","author":"Carpenter","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"26","key":"10.1016\/j.bcp.2021.114810_b0810","doi-asserted-by":"crossref","first-page":"E5207","DOI":"10.1073\/pnas.1617467114","article-title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing","volume":"114","author":"Fei","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2021.114810_b0815","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cca.2020.04.040","article-title":"Heterogeneous nuclear ribonucleoprotein (hnRNPL) in cancer","volume":"507","author":"Gu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bcp.2021.114810_b0820","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.leukres.2016.08.006","article-title":"Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS)","volume":"49","author":"Berman","year":"2016","journal-title":"Leuk. Res."},{"issue":"12","key":"10.1016\/j.bcp.2021.114810_b0825","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0145-2126(02)00061-9","article-title":"The study for loss of bcl-xs expression as a prognostic factor in acute myeloid leukemia","volume":"26","author":"Yamaguchi","year":"2002","journal-title":"Leuk. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:59:53Z","timestamp":1777413593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":165,"alternative-id":["S0006295221004263"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114810","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of alternative splicing on mechanisms of resistance to anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114810"}}